https://ift.tt/3h8r8Mc An expert panel of the country's central drug authority on Wednesday recommended against granting permission to the Serum Institute of India (SII) to conduct the phase 2/3 trial of COVID-19 vaccine Covovax on children aged two to 17 years, sources said.
Govt panel recommends against Covovax trial on children aged 2-17 years: Report
Reviewed by MITESH
on
June 30, 2021
Rating: 5
No comments